Dendritic Cell (DC) Maturation Assay

MH Markus Haug
GB Gaute Brede
MH Monika Håkerud
AN Anne Grete Nedberg
OG Odrun A. Gederaas
TF Trude H. Flo
VE Victoria T. Edwards
PS Pål K. Selbo
AH Anders Høgset
ØH Øyvind Halaas
request Request a Protocol
ask Ask a question
Favorite

Immature BMDCs (5 × 105) were incubated in 6-well plates ± TPCS2a overnight at 37°C, 5% CO2 in the dark. TPCS2a was washed (PBS, 3×) from the cells and cells were incubated for additional 4 h before light treatment. Lipopolysaccharide (LPS) from E. coli (100 ng/ml, Sigma) was used as a positive control to induce BMDC maturation, untreated cells were used as negative control. 18 h post light treatment, cells were scraped and stained with fluorescence-labeled anti-CD11c (FITC or PE, clone HL3, BD Biosciences), anti-MHC class II (I-Ab, Alexa Fluor 488 or APC, clone AF6-120.1, BioLegend), and anti-CD86 (PE, clone GL1, BioLegend) antibodies. Unlabeled anti-CD16/32 (clone 93, eBioscience) was used to block Fc receptor binding. Flow cytometric analysis of the cells was performed on a BD LSR II flow cytometer (BD Biosciences) and data analysis performed using FlowJo software (v10.0.7, FlowJo, LLC).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A